Viewing Study NCT00527020

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:27 AM
Ignite Modification Date: 2026-03-02 @ 8:04 AM
Study NCT ID: NCT00527020
Status: COMPLETED
Last Update Posted: 2017-08-04
First Post: 2007-09-06
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: First Time in Human Study With GSK1018921
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Schizophrenia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None qEEG, View
None GlyT-1 inhibitor, View
None ERP View
None GSK1018921, View
None FTIH, View
None schizophrenia, View
None single-dose, View
None healthy volunteers, View
None MMN, View